Global Parenteral Nutrition Market Size, Share, Growth, Industry Trends, Competitive Analysis and Forecast to 2030

Report ID: RC6470 | Report Format: PDF + Excel | Starting Price: 3600/- USD | Last Updated: June 20th, 2023

The global parenteral nutrition market size is anticipated to register a significant CAGR of over 5% during the forecast period and was estimated at over USD 5.5 billion in 2020. Clinical nutrition is critical to combating malnutrition during hospitalization and the rising prevalence of chronic diseases around the world is a major factor to drive the market growth. Furthermore, the rapid growth in the geriatric population and the increasing expenditure on healthcare is further expected to fuel the market over the forecast period from 2021 to 2027. Moreover, the increasing demand for low-cost parenteral nutrition and the growing popularity of intravenous vitamin C is projected to propel the market.

Market Drivers:

Rising Prevalence of Chronic Diseases: The increasing prevalence of chronic diseases such as cancer, gastrointestinal disorders, and malnutrition drives the demand for parenteral nutrition. Patients with these conditions often require specialized nutrition support when they are unable to consume food orally or absorb nutrients adequately through the gastrointestinal tract.

Growing Aging Population: The aging population is a significant driver of the parenteral nutrition market. Elderly individuals often face medical conditions that impact their ability to eat or absorb nutrients, necessitating the use of parenteral nutrition as a source of essential nutrients.

Hospitalization and Critical Care: Parenteral nutrition plays a vital role in the management of critically ill patients and those undergoing major surgeries who cannot receive adequate nutrition orally. Hospitalizations and critical care scenarios, where patients require intravenous feeding, contribute to the demand for parenteral nutrition.

Technological Advancements and Product Innovations: Advances in parenteral nutrition formulations, delivery systems, and compounding techniques have improved the safety, efficacy, and convenience of these products. Technological innovations, such as ready-to-use premixed parenteral nutrition solutions and advanced infusion pumps, drive market growth.

Increasing Awareness about Clinical Nutrition: There is growing awareness among healthcare professionals about the importance of optimal nutrition in patient care. The recognition of the impact of nutrition on patient outcomes has led to an increased emphasis on providing appropriate nutrition support, including parenteral nutrition, in various healthcare settings.

Homecare Settings and Ambulatory Infusion: The shift towards home-based healthcare and ambulatory infusion services has expanded the use of parenteral nutrition outside of traditional hospital settings. This trend allows patients to receive parenteral nutrition in the comfort of their homes, contributing to market growth.

Complex Gastrointestinal Surgeries: Gastrointestinal surgeries, such as bowel resections and bypass procedures, often result in temporary or permanent malabsorption of nutrients. Parenteral nutrition plays a crucial role in supporting patients during the recovery phase, promoting wound healing and minimizing the risk of malnutrition.

Nutritional Support in Pediatric Patients: Pediatric patients with congenital disorders, gastrointestinal diseases, or inadequate oral intake may require parenteral nutrition to meet their nutritional needs. The demand for parenteral nutrition in the pediatric population contributes to market growth.

Regulatory Support and Guidelines: The establishment of guidelines and regulations by healthcare regulatory bodies and professional organizations promotes the safe and appropriate use of parenteral nutrition. These regulations ensure quality control, product safety, and standardization, fostering market growth.

Increased Research and Development: Ongoing research and development activities focused on improving parenteral nutrition formulations, delivery methods, and addressing specific patient needs drive market growth. The development of specialized parenteral nutrition solutions tailored to specific patient populations and conditions further expands the market.

Market Outlook:

Benchmark Year 2022
Market Size > USD 5.5 Billion in 2020
Market Growth (CAGR) > 5% (2023-2030)
Largest Market Share North America
Analysis Period 2020-2030
Market Players Allergan plc, Amanta Healthcare Ltd, B. Braun Melsungen AG, Baxter International Inc., and Fresenius KABI AG

Market Insights:

The global parenteral nutrition market is bifurcated into type, consumer type, end-user, and geography. On the basis of type, the market is further segmented into Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, and others. The single-dose amino acid solution segment dominated the global market in 2020 and expected to cover a major market share of over one-third percent of the market by 2027. The increasing adoption of the product due to the availability of various nutritional products such as vitamins, dextrose, and minerals is anticipated to drive the segment growth. In contrast, the parenteral lipid emulsion segment is accounted to grow at a fast growth rate over the forecast period.

Parenteral Nutrition Market Forecast & Trends

To know more about the study, request a free report sample

The parenteral nutrition comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2021 to 2027. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

The parenteral nutrition market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

  • 2018-19 – Historical Year
  • 2020 – Base Year
  • 2021-2027 – Forecast Period

Market Segmentation:

By Type:

  • Single Dose Amino Acid Solution
  • Parenteral Lipid Emulsion
  • Carbohydrates
  • Trace Elements
  • Vitamins & Minerals

By Consumer Type:

  • Children & Newborns
  • Adults

By End-User:

  • Hospitals
  • Clinics
  • Home Care
  • Other

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Geographic Coverage:

Geographically, North America dominated the global parenteral nutrition market in 2020 and accounted to holds the largest market share of over one-third percent of the market. The technological advancement in healthcare and the increasing investment in research and development are some prominent factor to drive the market growth in the region. Furthermore, the increasing awareness regarding home healthcare products is anticipated to fuel the market in North America. On the other hand, the Asia Pacific is expected to grow at a fast growth rate over the forecast period.

Competition Assessment:

Some of the major players operating in the global parenteral nutrition market are Allergan plc, Amanta Healthcare Ltd, B. Braun Melsungen AG, Baxter International Inc., and Fresenius KABI AG. Companies are exploring markets through expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

  • Allergan plc
  • Amanta Healthcare Ltd
  • Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius KABI AG
  • Grifols International S.A.
  • ICU Medical Inc.
  • Otsuka Pharmaceutical Factory Inc.
  • Sichuan Kelun Pharmaceutical Co. Ltd.
  • Sino-Swed Pharmaceutical Corp. Ltd.

Key Questions Answered by Parenteral Nutrition Market Report

  • Global parenteral nutrition market forecasts from 2021-2027
  • Regional parenteral nutrition market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
  • Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
  • Parenteral nutrition submarket forecasts from 2021-2027 covering the market by type, by consumer type, by end-user, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis pertaining to the parenteral nutrition market
  • Analysis of the key factors driving and restraining the growth of the global, regional and country-level parenteral nutrition markets from 2021-2027
  • Competitive Landscape and market positioning of top 10 players operating in the parenteral nutrition market
Table of Content:

1. Preface


1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

 

2. Executive Summary


2.1. Global Parenteral Nutrition Market Portraiture
2.2. Global Parenteral Nutrition Market, by Type, 2020 (USD Mn)
2.3. Global Parenteral Nutrition Market, by Consumer Type, 2020 (USD Mn)
2.4. Global Parenteral Nutrition Market, by End-User, 2020 (USD Mn)
2.5. Global Parenteral Nutrition Market, by Geography, 2020 (USD Mn)

 

3. Global Parenteral Nutrition Market Analysis


3.1. Parenteral Nutrition Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. COVID-19 Impact Analysis

 

4. Global Parenteral Nutrition Market By Type, 2018 – 2027 (USD Mn)


4.1. Overview
4.2. Single Dose Amino Acid Solution
4.3. Parenteral Lipid Emulsion
4.4. Carbohydrates
4.5. Trace Elements
4.6. Vitamins & Minerals

 

5. Global Parenteral Nutrition Market By Consumer Type, 2018 – 2027 (USD Mn)


5.1. Overview
5.2. Children & Newborns
5.3. Adults

 

6. Global Parenteral Nutrition Market By End-User, 2018 – 2027 (USD Mn)


6.1. Overview
6.2. Hospitals
6.3. Clinics
6.4. Home Care
6.5. Other

 

7. North America Parenteral Nutrition Market Analysis and Forecast, 2018 – 2027 (USD Mn)


7.1.1. Overview
7.1.2. North America Parenteral Nutrition Market by Type (2018-2027 USD Mn)
7.1.3. North America Parenteral Nutrition Market by Consumer Type (2018-2027 USD Mn)
7.1.4. North America Parenteral Nutrition Market by End-User (2018-2027 USD Mn)
7.1.5. North America Parenteral Nutrition Market by Country (2018-2027 USD Mn)
7.1.5.1. U.S.
7.1.5.1.1. U.S. Parenteral Nutrition Market by Type (2018-2027 USD Mn)
7.1.5.1.2. U.S. Parenteral Nutrition Market by Consumer Type (2018-2027 USD Mn)
7.1.5.1.3. U.S. Parenteral Nutrition Market by End-User (2018-2027 USD Mn)
7.1.5.2. Canada
7.1.5.2.1. Canada Parenteral Nutrition Market by Type (2018-2027 USD Mn)
7.1.5.2.2. Canada Parenteral Nutrition Market by Consumer Type (2018-2027 USD Mn)
7.1.5.2.3. Canada Parenteral Nutrition Market by End-User (2018-2027 USD Mn)

 

8. Europe Parenteral Nutrition Market Analysis and Forecast, 2018 – 2027 (USD Mn)


8.1.1. Overview
8.1.2. Europe Parenteral Nutrition Market by Type (2018-2027 USD Mn)
8.1.3. Europe Parenteral Nutrition Market by Consumer Type (2018-2027 USD Mn)
8.1.4. Europe Parenteral Nutrition Market by End-User (2018-2027 USD Mn)
8.1.5. Europe Parenteral Nutrition Market by Country (2018-2027 USD Mn)
8.1.5.1. Germany
8.1.5.1.1. Germany Parenteral Nutrition Market by Type (2018-2027 USD Mn)
8.1.5.1.2. Germany Parenteral Nutrition Market by Consumer Type (2018-2027 USD Mn)
8.1.5.1.3. Germany Parenteral Nutrition Market by End-User (2018-2027 USD Mn)
8.1.5.2. U.K.
8.1.5.2.1. U.K. Parenteral Nutrition Market by Type (2018-2027 USD Mn)
8.1.5.2.2. U.K. Parenteral Nutrition Market by Consumer Type (2018-2027 USD Mn)
8.1.5.2.3. U.K. Parenteral Nutrition Market by End-User (2018-2027 USD Mn)
8.1.5.3. France
8.1.5.3.1. France Parenteral Nutrition Market by Type (2018-2027 USD Mn)
8.1.5.3.2. France Parenteral Nutrition Market by Consumer Type (2018-2027 USD Mn)
8.1.5.3.3. France Parenteral Nutrition Market by End-User (2018-2027 USD Mn)
8.1.5.4. Italy
8.1.5.4.1. Italy Parenteral Nutrition Market by Type (2018-2027 USD Mn)
8.1.5.4.2. Italy Parenteral Nutrition Market by Consumer Type (2018-2027 USD Mn)
8.1.5.4.3. Italy Parenteral Nutrition Market by End-User (2018-2027 USD Mn)
8.1.5.5. Rest of Europe
8.1.5.5.1. Rest of Europe Parenteral Nutrition Market by Type (2018-2027 USD Mn)
8.1.5.5.2. Rest of Europe Parenteral Nutrition Market by Consumer Type (2018-2027 USD Mn)
8.1.5.5.3. Rest of Europe Parenteral Nutrition Market by End-User (2018-2027 USD Mn)

 

9. Asia Pacific Parenteral Nutrition Market Analysis and Forecast, 2018 – 2027 (USD Mn)


9.1.1. Overview
9.1.2. Asia Pacific Parenteral Nutrition Market by Type (2018-2027 USD Mn)
9.1.3. Asia Pacific Parenteral Nutrition Market by Consumer Type (2018-2027 USD Mn)
9.1.4. Asia Pacific Parenteral Nutrition Market by End-User (2018-2027 USD Mn)
9.1.5. Asia Pacific Parenteral Nutrition Market by Country (2018-2027 USD Mn)
9.1.5.1. China
9.1.5.1.1. China Parenteral Nutrition Market by Type (2018-2027 USD Mn)
9.1.5.1.2. China Parenteral Nutrition Market by Consumer Type (2018-2027 USD Mn)
9.1.5.1.3. China Parenteral Nutrition Market by End-User (2018-2027 USD Mn)
9.1.5.2. Japan
9.1.5.2.1. Japan Parenteral Nutrition Market by Type (2018-2027 USD Mn)
9.1.5.2.2. Japan Parenteral Nutrition Market by Consumer Type (2018-2027 USD Mn)
9.1.5.2.3. Japan Parenteral Nutrition Market by End-User (2018-2027 USD Mn)
9.1.5.3. Rest of Asia Pacific
9.1.5.3.1. Rest of Asia Pacific Parenteral Nutrition Market by Type (2018-2027 USD Mn)
9.1.5.3.2. Rest of Asia Pacific Parenteral Nutrition Market by Consumer Type (2018-2027 USD Mn)
9.1.5.3.3. Rest of Asia Pacific Parenteral Nutrition Market by End-User (2018-2027 USD Mn)

 

10. Latin America (LATAM) Parenteral Nutrition Market Analysis and Forecast, 2018 – 2027 (USD Mn)


10.1.1. Overview
10.1.2. Latin America Parenteral Nutrition Market by Type (2018-2027 USD Mn)
10.1.3. Latin America Parenteral Nutrition Market by Consumer Type (2018-2027 USD Mn)
10.1.4. Latin America Parenteral Nutrition Market by End-User (2018-2027 USD Mn)
10.1.5. Latin America Parenteral Nutrition Market by Country (2018-2027 USD Mn)
10.1.5.1. Brazil
10.1.5.1.1. Brazil Parenteral Nutrition Market by Type (2018-2027 USD Mn)
10.1.5.1.2. Brazil Parenteral Nutrition Market by Consumer Type (2018-2027 USD Mn)
10.1.5.1.3. Brazil Parenteral Nutrition Market by End-User (2018-2027 USD Mn)
10.1.5.2. Mexico
10.1.5.2.1. Mexico Parenteral Nutrition Market by Type (2018-2027 USD Mn)
10.1.5.2.2. Mexico Parenteral Nutrition Market by Consumer Type (2018-2027 USD Mn)
10.1.5.2.3. Mexico Parenteral Nutrition Market by End-User (2018-2027 USD Mn)
10.1.5.3. Rest of Latin America
10.1.5.3.1. Rest of Latin America Parenteral Nutrition Market by Type (2018-2027 USD Mn)
10.1.5.3.2. Rest of Latin America Parenteral Nutrition Market by Consumer Type (2018-2027 USD Mn)
10.1.5.3.3. Rest of Latin America Parenteral Nutrition Market by End-User (2018-2027 USD Mn)

 

11. Middle East and Africa Parenteral Nutrition Market Analysis and Forecast, 2018 – 2027 (USD Mn)


11.1.1. Overview
11.1.2. MEA Parenteral Nutrition Market by Type (2018-2027 USD Mn)
11.1.3. MEA Parenteral Nutrition Market by Consumer Type (2018-2027 USD Mn)
11.1.4. MEA Parenteral Nutrition Market by End-User (2018-2027 USD Mn)
11.1.5. Middle East and Africa Parenteral Nutrition Market, by Country (2018-2027 USD Mn)
11.1.5.1. GCC
11.1.5.1.1. GCC Parenteral Nutrition Market by Type (2018-2027 USD Mn)
11.1.5.1.2. GCC Parenteral Nutrition Market by Consumer Type (2018-2027 USD Mn)
11.1.5.1.3. GCC Parenteral Nutrition Market by End-User (2018-2027 USD Mn)
11.1.5.2. South Africa
11.1.5.2.1. South Africa Parenteral Nutrition Market by Type (2018-2027 USD Mn)
11.1.5.2.2. South Africa Parenteral Nutrition Market by Consumer Type (2018-2027 USD Mn)
11.1.5.2.3. South Africa Parenteral Nutrition Market by End-User (2018-2027 USD Mn)
11.1.5.3. Rest of MEA
11.1.5.3.1. Rest of MEA Parenteral Nutrition Market by Type (2018-2027 USD Mn)
11.1.5.3.2. Rest of MEA Parenteral Nutrition Market by Consumer Type (2018-2027 USD Mn)
11.1.5.3.3. Rest of MEA Parenteral Nutrition Market by End-User (2018-2027 USD Mn)

 

12. Company Profiles


12.1. Allergan plc
12.1.1. Business Description
12.1.2. Financial Health and Budget Allocation
12.1.3. Product Positions/Portfolio
12.1.4. Recent Development
12.1.5. SWOT Analysis
12.2. Amanta Healthcare Ltd
12.2.1. Business Description
12.2.2. Financial Health and Budget Allocation
12.2.3. Product Positions/Portfolio
12.2.4. Recent Development
12.2.5. SWOT Analysis
12.3. B. Braun Melsungen AG
12.3.1. Business Description
12.3.2. Financial Health and Budget Allocation
12.3.3. Product Positions/Portfolio
12.3.4. Recent Development
12.3.5. SWOT Analysis
12.4. Baxter International Inc.
12.4.1. Business Description
12.4.2. Financial Health and Budget Allocation
12.4.3. Product Positions/Portfolio
12.4.4. Recent Development
12.4.5. SWOT Analysis
12.5. Fresenius KABI AG
12.5.1. Business Description
12.5.2. Financial Health and Budget Allocation
12.5.3. Product Positions/Portfolio
12.5.4. Recent Development
12.5.5. SWOT Analysis
12.6. Grifols International S.A.
12.6.1. Business Description
12.6.2. Financial Health and Budget Allocation
12.6.3. Product Positions/Portfolio
12.6.4. Recent Development
12.6.5. SWOT Analysis
12.7. ICU Medical Inc.
12.7.1. Business Description
12.7.2. Financial Health and Budget Allocation
12.7.3. Product Positions/Portfolio
12.7.4. Recent Development
12.7.5. SWOT Analysis
12.8. Otsuka Pharmaceutical Factory Inc.
12.8.1. Business Description
12.8.2. Financial Health and Budget Allocation
12.8.3. Product Positions/Portfolio
12.8.4. Recent Development
12.8.5. SWOT Analysis
12.9. Sichuan Kelun Pharmaceutical Co. Ltd.
12.9.1. Business Description
12.9.2. Financial Health and Budget Allocation
12.9.3. Product Positions/Portfolio
12.9.4. Recent Development
12.9.5. SWOT Analysis
12.10. Sino-Swed Pharmaceutical Corp. Ltd.
12.10.1. Business Description
12.10.2. Financial Health and Budget Allocation
12.10.3. Product Positions/Portfolio
12.10.4. Recent Development
12.10.5. SWOT Analysis
Fill the given form to inquiry before buying for Parenteral Nutrition Market Report

(Additional country analysis and conmapny analysis will be added according to the request, we provide free report customization)
(Report covers the impact of COVID-19 on the market)

Request Report Sample
Inquiry Before Buying
Schedule a Call


Select License Type
$ 3600/- Single User License
$ 6995/- Corporate License

Paypal Certified Payment
For Any Assitance

Email: sales@researchcorridor.com
Why To Choose Us:
  • Markets in over 100+ countries analyzed granularly
  • 35% of our total client are returning clients
  • 1000+ customers globally
  • 100+ paid data sources mined to bring cutting-edge insights
  • 24x5 availability - we are always there when you need us
  • "Free of Cost Report Customization" is available
  • Request a regional report at Best Price

Impacts of COVID-19
COVID-19 Impact on the Parenteral Nutrition Market


Our Clients